Patents by Inventor Tsu-Shuen Tsao

Tsu-Shuen Tsao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multiplexed immunohistochemistry using recombinant antibodies with epitope tags
    Patent number: 11988673
    Abstract: The present disclosure is directed to epitope-tagged antibodies, as well as methods of employing the epitope-tagged antibodies for detecting one or more targets in a biological sample, e.g. a tissue sample.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: May 21, 2024
    Assignee: Ventana Medical Systems, Inc.
    Inventors: Michael Farrell, Antony Hubbard, Eric May, Lei Tang, Tsu-Shuen Tsao, Wenjun Zhang
  • MULTIPLEXED IMMUNOHISTOCHEMISTRY USING RECOMBINANT ANTIBODIES WITH EPITOPE TAGS
    Publication number: 20220057408
    Abstract: The present disclosure is directed to epitope-tagged antibodies, as well as methods of employing the epitope-tagged antibodies for detecting one or more targets in a biological sample, e.g. a tissue sample.
    Type: Application
    Filed: July 30, 2021
    Publication date: February 24, 2022
    Inventors: Michael Farrell, Antony Hubbard, Eric May, Lei Tang, Tsu-Shuen Tsao, Wenjun Zhang
  • DETERMINATION OF PARKINSON'S DISEASE
    Publication number: 20220018851
    Abstract: Methods and compositions for accurate identification of Parkinson's disease are disclosed. More particularly, the disclosure is directed to the determination of Parkinson's disease in ante-mortem tissue samples.
    Type: Application
    Filed: August 8, 2019
    Publication date: January 20, 2022
    Inventors: Christian Czech, Sebastian Dziadek, Lidija Pestic-Dragovich, Lei Tang, Thomas Kremer, Wagner Marcelo Zago, Tsu-Shuen Tsao, Adriana Racolta, Marta Canamero, Ronald Torres, Mirko Ritter
  • Multiplexed immunohistochemistry using recombinant antibodies with epitope tags
    Patent number: 11112413
    Abstract: The present disclosure is directed to epitope-tagged antibodies, as well as methods of employing the epitope-tagged antibodies for detecting one or more targets in a biological sample, e.g. a tissue sample.
    Type: Grant
    Filed: September 6, 2018
    Date of Patent: September 7, 2021
    Assignee: Ventana Medical Systems, Inc.
    Inventors: Michael Farrell, Antony Hubbard, Eric May, Lei Tang, Tsu-Shuen Tsao, Wenjun Zhang
  • MULTIPLEXED IMMUNOHISTOCHEMISTRY USING RECOMBINANT ANTIBODIES WITH EPITOPE TAGS
    Publication number: 20190094242
    Abstract: The present disclosure is directed to epitope-tagged antibodies, as well as methods of employing the epitope-tagged antibodies for detecting one or more targets in a biological sample, e.g. a tissue sample.
    Type: Application
    Filed: September 6, 2018
    Publication date: March 28, 2019
    Inventors: Michael Farrell, Antony Hubbard, Eric May, Lei Tang, Tsu-Shuen Tsao, Wenjun Zhang
  • Use of ACRP30 Globular Head to Promote Increases in Muscle Mass and Muscle Differentiation
    Publication number: 20080274971
    Abstract: The present invention relates to the field of muscle research, in particular to the discovery of a compound effective for increasing muscle mass, muscle cell differentiation, and oxidation of free fatty acids in muscle, useful in methods of treating muscle-related diseases and disorders as well as for augmenting muscle mass in general. The muscle-related diseases or disorders envisaged to be treated by the methods of the invention include, but are not limited to, muscular dystrophy, and other conditions resulting in muscle atrophy or muscle wasting.
    Type: Application
    Filed: June 27, 2008
    Publication date: November 6, 2008
    Applicant: SERONO GENETICS INSTITUTE S.A.
    Inventors: Harvey Lodish, Joachim Fruebis, Tsu-Shuen Tsao, Bernard Bihain
  • Use of Acrp30 globular head to promote increases in muscle mass and muscle differentiation
    Patent number: 7405193
    Abstract: The present invention relates to the field of muscle research, in particular to the discovery of a compound effective for increasing muscle mass, muscle cell differentiation, and oxidation of free fatty acids in muscle, useful in methods of treating muscle-related diseases and disorders as well as for augmenting muscle mass in general. The muscle-related diseases or disorders envisaged to be treated by the methods of the invention include, but are not limited to, muscular dystrophy, and other conditions resulting in muscle atrophy or muscle wasting.
    Type: Grant
    Filed: May 22, 2001
    Date of Patent: July 29, 2008
    Assignee: Serono Genetics Institute S.A.
    Inventors: Harvey Lodish, Joachim Fruebis, Tsu-Shuen Tsao, Bernard Bihain
  • Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation
    Publication number: 20060035824
    Abstract: The present invention relates to the field of muscle research, in particular to the discovery of a compound effective for increasing muscle mass, muscle cell differentiation, and oxidation of free fatty acids in muscle, useful in methods of treating muscle-related diseases and disorders as well as for augmenting muscle mass in general. The muscle-related diseases or disorders envisaged to be treated by the methods of the invention include, but are not limited to, muscular dystrophy, and other conditions resulting in muscle atrophy or muscle wasting.
    Type: Application
    Filed: May 22, 2001
    Publication date: February 16, 2006
    Applicant: Genset
    Inventors: Harvey Lodish, Joachim Fruebis, Tsu-Shuen Tsao, Bernard Bihain